Allecra Therapeutics Is A Clinical Stage Biopharmaceutical Company Founded In 2013With Operations In France And Germanythe Company Focuses On Developing Novel Treatments To Address Antibiotic Resistanceparticularly Against Drug Resistant Bacterial Infectionsone Of Its Key Products Is Exblifepcefepime Enmetazobactam Which Has Received U Sfda Approval For Treating Complicated Urinary Tract Infectionsincluding Pyelonephritisin Adultsthis Approval Includes A Five Year Marketing Exclusivity Extension Under The Generating Antibiotic Incentives Now Actgain Act Which Encourages The Development Of New Anti Infective Therapiesallecra Therapeutics Is Also In Discussions With Strategic Partners For The Launch Of Exblifep In The U Smarket
